IVD Technology

The in vitro diagnostic (IVD) medical device market is on the cusp of transformative growth, driven by technological advancements, increased prevalence of chronic diseases, and a growing demand for early and accurate diagnostics. IVD devices, including reagents, test kits, and laboratory equipment,

The in vitro diagnostics (IVD) raw materials market is set to experience remarkable growth over the next decade, driven by technological advancements and increasing demands in healthcare. As the world's health needs evolve, this market, valued at USD 14,560 million in 2023, is anticipated to

The Transitional Coverage for Emerging Technologies (TCET) Medicare payment pathway, detailed in a recent final notice by the Centers for Medicare & Medicaid Services (CMS), promises to revolutionize the way breakthrough medical technologies receive coverage and reimbursement under Medicare.

In the dynamic landscape of European healthcare, the In-Vitro Diagnostics (IVD) market is experiencing significant transformation. With a predicted compound annual growth rate (CAGR) of 2.23%, the IVD sector in Europe is forecasted to expand from a worth of $27.75 billion in 2023 to an estimated

In-Vitro Diagnostics (IVDs) are essential elements within healthcare, crucial for disease prevention, precise diagnostics, and effective treatment protocols. With advancements in medical technology, the need for congruent regulatory frameworks is apparent, ensuring these tools maintain their

The realm of in vitro diagnostics is one where precision and trustworthiness are paramount. Stepping up to this critical task is LGC Biosearch Technologies, renowned for crafting superior oligonucleotides crucial to diagnostic tests. With a rich history spanning over 20 years, their prowess in